{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:01:20Z","timestamp":1784714480137,"version":"3.55.0"},"reference-count":25,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.3109\/10428194.2015.1090573","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T06:45:51Z","timestamp":1442385951000},"page":"1182-1188","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia"],"prefix":"10.3109","volume":"57","author":[{"given":"Vasiliki","family":"Papadopoulou","sequence":"first","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Kontandreopoulou","sequence":"additional","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Panayiotidis","sequence":"additional","affiliation":[{"name":"Molecular Hematology Laboratory, 1st Department of Propaedeutic Medicine, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Roumelioti","sequence":"additional","affiliation":[{"name":"Molecular Hematology Laboratory, 1st Department of Propaedeutic Medicine, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Angelopoulou","sequence":"additional","affiliation":[{"name":"Hematology Department, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Kyriazopoulou","sequence":"additional","affiliation":[{"name":"Hematology Department, University of Ioannina Medical School","place":["Ioannina, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis T.","family":"Diamantopoulos","sequence":"additional","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vaiopoulos","sequence":"additional","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Variami","sequence":"additional","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kotsianidis","sequence":"additional","affiliation":[{"name":"Hematology Department, Democritus University of Thrace Medical School","place":["Xanthi, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Athina Viniou","sequence":"additional","affiliation":[{"name":"Hematology Unit, 1st Department of Internal Medicine, Laiko Hospital, University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien SG","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, et\u00a0al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994\u20131004.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro.","volume":"99","author":"Graham SM","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, et\u00a0al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002; 99: 319\u2013325.","journal-title":"Blood"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/asheducation-2009.1.461","article-title":"Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance.","volume":"2009","author":"Bixby D","year":"2009","unstructured":"Bixby D, Talpaz M. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance. Hematology Am Soc Hematol Educ Program 2009; 2009: 461\u2013476.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia.","volume":"25","author":"Bixby D","year":"2011","unstructured":"Bixby D, Talpaz M. Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 2011; 25: 7\u201322.","journal-title":"Leukemia"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semcdb.2014.09.021","article-title":"Mining the function of protein tyrosine phosphatases in health and disease.","volume":"37","author":"Lee H","year":"2015","unstructured":"Lee H, Yi JS, Lawan A, et\u00a0al. Mining the function of protein tyrosine phosphatases in health and disease. Semin Cell Dev Biol 2015; 37: 66\u201372.","journal-title":"Semin Cell Dev Biol"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.onc.1202117","article-title":"Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase.","volume":"17","author":"Liedtke M","year":"1998","unstructured":"Liedtke M, Pandey P, Kumar S, et\u00a0al. Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase. Oncogene 1998; 17: 1889\u20131892.","journal-title":"Oncogene"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"12233","DOI":"10.1073\/pnas.210253497","article-title":"BCR\/ABL inhibition by an escort\/phosphatase fusion protein.","volume":"97","author":"Lim YM","year":"2000","unstructured":"Lim YM, Wong S, Lau G, et\u00a0al. BCR\/ABL inhibition by an escort\/phosphatase fusion protein. Proc Natl Acad Sci U S A 2000; 97: 12233\u201312238.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1073\/pnas.95.24.14094","article-title":"Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells.","volume":"95","author":"LaMontagne KR","year":"1998","unstructured":"LaMontagne KR Jr, Hannon G, Tonks NK. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. Proc Natl Acad Sci U S A 1998; 95: 14094\u201314099.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0092-8674(93)90369-2","article-title":"Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.","volume":"73","author":"Shultz LD","year":"1993","unstructured":"Shultz LD, Schweitzer PA, Rajan TV, et\u00a0al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993; 73: 1445\u20131454.","journal-title":"Cell"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4049\/jimmunol.1203040","article-title":"The role of the Syk\/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling.","volume":"193","author":"Alsadeq A","year":"2014","unstructured":"Alsadeq A, Hobeika E, Medgyesi D, et\u00a0al. The role of the Syk\/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol 2014; 193: 268\u2013276.","journal-title":"J Immunol"},{"key":"e_1_3_2_12_1","first-page":"1726","article-title":"Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.","volume":"2012","author":"Tsantikos E","unstructured":"Tsantikos E, Maxwell MJ, Kountouri N, et\u00a0al. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development. J Immunol 2012; 189: 1726\u20131736.","journal-title":"J Immunol"},{"key":"e_1_3_2_13_1","first-page":"471","article-title":"SH2-containing phosphotyrosine phosphatase SHP-1 is involved in BCR-ABL signal transduction pathways.","volume":"11","author":"Tauchi T","year":"1997","unstructured":"Tauchi T, Ohyashiki K, Yamashita Y, et\u00a0al. SH2-containing phosphotyrosine phosphatase SHP-1 is involved in BCR-ABL signal transduction pathways. Int J Oncol 1997; 11: 471\u2013475.","journal-title":"Int J Oncol"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2005.10.015","article-title":"The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein.","volume":"8","author":"Neviani P","year":"2005","unstructured":"Neviani P, Santhanam R, Trotta R, et\u00a0al. The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein. Cancer Cell 2005; 8: 355\u2013368.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","first-page":"675429","DOI":"10.1155\/2013\/675429","article-title":"PP2A-Mediated Anticancer Therapy.","volume":"2013","author":"Chen W","year":"2013","unstructured":"Chen W, Wang Z, Jiang C, et\u00a0al. PP2A-Mediated Anticancer Therapy. Gastroenterol Res Pract 2013; 2013: 675429.","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)62535-7","article-title":"Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: combination analysis with cDNA expression array and tissue microarray.","volume":"159","author":"Oka T","year":"2001","unstructured":"Oka T, Yoshino T, Hayashi K, et\u00a0al. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: combination analysis with cDNA expression array and tissue microarray. Am J Pathol 2001; 159: 1495\u20131505.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1182\/blood-2003-06-2007","article-title":"SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway.","volume":"103","author":"Chim CS","year":"2004","unstructured":"Chim CS, Fung TK, Cheung WC, et\u00a0al. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak\/STAT pathway. Blood 2004; 103: 4630\u20134635.","journal-title":"Blood"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.2178","article-title":"Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.","volume":"212","author":"Amin HM","year":"2007","unstructured":"Amin HM, Hoshino K, Yang H, et\u00a0al. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia. J Pathol 2007; 212: 402\u2013410.","journal-title":"J Pathol"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3109\/10428194.2014.969258","article-title":"Differential expression of SHP-1 in chronic myeloid leukemia.","volume":"56","author":"Kaeda J","year":"2015","unstructured":"Kaeda J, Neuman D, Bonecker S, et\u00a0al. Differential expression of SHP-1 in chronic myeloid leukemia. Leuk Lymphoma 2015; 56: 1547\u20131549.","journal-title":"Leuk Lymphoma"},{"key":"e_1_3_2_20_1","first-page":"6390","article-title":"Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas.","volume":"62","author":"Oka T","year":"2002","unstructured":"Oka T, Ouchida M, Koyama M, et\u00a0al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas. Cancer Res 2002; 62: 6390\u20136394.","journal-title":"Cancer Res"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1182\/blood-2011-03-341073","article-title":"SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.","volume":"118","author":"Esposito N","year":"2011","unstructured":"Esposito N, Colavita I, Quintarelli C, et\u00a0al. SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. Blood 2011; 118: 3634\u20133644.","journal-title":"Blood"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygeno.2013.10.001","article-title":"Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells.","volume":"102","author":"Evren S","year":"2013","unstructured":"Evren S, Wan S, Ma XZ, et\u00a0al. Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells. Genomics 2013; 102: 491\u2013499.","journal-title":"Genomics"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1189\/jlb.0608383","article-title":"Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.","volume":"85","author":"Nakase K","year":"2009","unstructured":"Nakase K, Cheng J, Zhu Q, et\u00a0al. Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells. J Leukoc Biol 2009; 85: 165\u2013174.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.","volume":"92","author":"Bose S","year":"1998","unstructured":"Bose S, Deininger M, Gora-Tybor J, et\u00a0al. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 1998; 92: 3362\u20133367.","journal-title":"Blood"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3892\/or.2014.3098","article-title":"Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia.","volume":"31","author":"Li Y","year":"2014","unstructured":"Li Y, Yang L, Pan Y, et\u00a0al. Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia. Oncol Rep 2014; 31: 2438\u20132446.","journal-title":"Oncol Rep"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.2741\/3051","article-title":"Protein tyrosine phosphatases in the JAK\/STAT pathway.","volume":"13","author":"Xu D","year":"2008","unstructured":"Xu D, Qu CK. Protein tyrosine phosphatases in the JAK\/STAT pathway. Front Biosci 2008; 13: 4925\u20134932.","journal-title":"Front Biosci"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1090573","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2015.1090573","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2015.1090573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:05:49Z","timestamp":1784711149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2015.1090573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["10.3109\/10428194.2015.1090573"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2015.1090573","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}